Free Trial
OTCMKTS:CLPBY

Coloplast A/S 11/5/2024 Earnings Report

Coloplast A/S logo
$9.38 +0.01 (+0.05%)
As of 02:13 PM Eastern

Coloplast A/S EPS Results

Actual EPS
$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Coloplast A/S Revenue Results

Actual Revenue
$1.02 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Coloplast A/S Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Coloplast A/S' next earnings date is estimated for Tuesday, August 19, 2025, based on past reporting schedules.

Conference Call Resources

Coloplast A/S Earnings Headlines

CLPBY - Coloplast AS ADR Valuation - Morningstar
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
CLPBY Coloplast A/S - Seeking Alpha
Coloplast: Finally Getting Buyable
See More Coloplast A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Coloplast A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your email.

About Coloplast A/S

Coloplast A/S (OTCMKTS:CLPBY) is a Danish multinational company specializing in the development, manufacturing and marketing of medical devices and services within wound and skin care, ostomy care, continence care and urology. Founded in 1954 by Aage Louis-Hansen, Coloplast has grown from a small family‐run enterprise into a global healthcare innovator. The company’s mission centers on creating solutions that make life easier for people with intimate healthcare needs, combining user‐centric design with clinical expertise.

The company’s product portfolio spans four primary business areas. In ostomy care, Coloplast offers a range of pouches, accessories and support services designed for individuals who have undergone ostomy surgery. Its continence and urology product lines include catheters, continence care packs and related accessories, while the wound and skin care segment delivers advanced dressings, skin cleansers and protective products for chronic wounds, surgical wounds and pressure ulcers. Many solutions are complemented by digital tools and educational resources, offering patients and caregivers guidance on proper use and self‐management.

Headquartered in Humlebæk, Denmark, Coloplast operates in more than 40 countries and maintains a strong presence across Europe, North America, Asia‐Pacific and emerging markets. Its extensive distribution network comprises direct sales teams, distributors and e‐commerce channels, allowing the company to adapt to local healthcare systems and regulatory environments. Coloplast invests heavily in research and development, collaborating with clinicians and patient advocacy groups to drive innovation and ensure product efficacy and safety.

The company is governed by an executive management team led by Chief Executive Officer Jakob Munk Knudsen, supported by senior leaders in research, manufacturing, sales and sustainability. Under their stewardship, Coloplast continues to pursue strategic initiatives aimed at expanding its global footprint, enhancing patient support programs and promoting environmental responsibility throughout its operations and supply chain.

View Coloplast A/S Profile

More Earnings Resources from MarketBeat